A Washington judge has ordered Albertsons Companies and its Safeway subsidiary to pay $900 million for helping fuel the state's opioid crisis, ruling on Thursday, November 5, that the grocery giant's pharmacies repeatedly filled prescriptions carrying clear warning signs of misuse and diversion without documenting that anyone had checked them. King County Superior Court Judge Janet Helson issued the judgment in Seattle at the end of a nine-week bench trial, finding that Albertsons created and maintained a public nuisance and violated Washington's Consumer Protection Act.
Source: Reuters via SRN News
The $900 million is made up of $800 million that must be paid into a court-supervised trust to fund an opioid abatement plan — treatment, harm reduction, prevention and coordination across Washington — and $100 million in civil penalties, plus the state's attorneys' fees and costs, which are still to be fixed. Albertsons and Safeway are jointly liable for most of the judgment. The court declined to order a separate restitution payment on top of the abatement fund.
Source: King County Superior Court findings, summarised by Corporate INTL
What the court found the pharmacies did
Pharmacists have a legal duty under state and federal law to identify, investigate and resolve 'red flags of diversion' — warning signs that a prescription may be misused or sold on — and to document that process before dispensing a controlled substance. The Attorney General's Office proved at trial that between 2006 and 2022, Albertsons pharmacies in Washington dispensed more than 641 million opioid pills, and unlawfully filled red-flagged opioid prescriptions more than 6.5 million times without documenting any effort to confirm they were written for legitimate medical purposes. The court's findings put red-flagged prescriptions at 61.6 percent of the total, and found that Albertsons, acting as distributor to its own stores, never reported a single suspicious order to the U.S. Drug Enforcement Administration.
Source: Washington Attorney General's Office
The trial evidence, as summarised by the Attorney General's Office, described corporate policies that put speed and profit ahead of those checks: pharmacists were discouraged from flagging problem prescribers, were in some cases not allowed to turn away prescriptions from known 'pill mill' doctors even after rival chains had blocked them, and stores were kept 'siloed' so they could not share warnings with each other. The state also presented evidence of chronic understaffing — pharmacists wrote to managers that reviewing prescriptions properly was 'impossible' at their workload, describing exhaustion, vomiting from dehydration and hunger, and warning that 'mistakes can easily be made to put someone's life at risk.' Inventory control failed too: in one case a Safeway employee stole more than 70,000 opioid pills from a North Bend pharmacy over two years before being caught, with further thefts of 12,000 pills in Leavenworth and 19,000 in Olympia.
How Judge Helson built the $900 million figure
The case, State of Washington v. Rite Aid Corp. et al., No. 22-2-20910-1 SEA, was filed on December 21, 2022 against Albertsons, Kroger and Rite Aid entities including Bartell Drugs, QFC and Fred Meyer. Every other defendant settled early or went through bankruptcy, leaving Albertsons as the sole defendant at a bench trial that ran from July 13 to September 14, 2026, with 45 witnesses and more than 600 exhibits. At closing, the state asked for $2.2 billion in abatement. Judge Helson found the true cost of abating the crisis to be no less than $24 billion and likely closer to $30 billion, held that it would not be equitable to make one company pay all of it, and fixed Albertsons' share at $800 million — refusing any discount for money other companies had already paid in settlements.
The penalty side of the judgment is unusually detailed. The court counted 11,953 distribution violations at $2,000 each and 6,280,313 dispensing violations at $50 each, which totals $337,921,650, and noted that Albertsons took in at least $296,025,684 on red-flagged prescriptions dispensed without documented due diligence. The judge then cut the penalty to $100 million — but only on condition that the $800 million abatement award stands. If the abatement award is reduced or overturned on appeal, the full $337.9 million penalty revives. Alongside the money, a permanent injunction requires Albertsons to document red-flag resolutions, maintain staffing sufficient for pharmacists to do the checks, run compliance reviews, and file sworn annual certifications for five years.
The human cost behind the case
More than 26,000 Washingtonians have died of an opioid overdose since 1999, including more than 7,400 in the last three years alone, and research cited by the Attorney General's Office estimates roughly ten times the death toll were living with opioid use disorder in 2023. The U.S. Centers for Disease Control and Prevention put the national economic burden of the epidemic at more than $1 trillion in 2017 alone, and Albertsons' own documents, cited by the state, acknowledge that four out of every five new heroin users begin with prescription pills — the pathway from a pharmacy counter to heroin and fentanyl that this case was about. Attorney General Nick Brown said: 'This is a victory for the people of Washington. When giant corporations put profits above safety, they will be held accountable. This verdict can't undo the devastating harms of the opioid crisis, but it will provide desperately needed resources to support treatment and prevent future crises.'
Source: Washington Attorney General's Office
Albertsons' response, and why Washington went to trial
Albertsons said in a statement that it is disappointed by the ruling, respectfully disagrees with its conclusions, and will evaluate all available options, including an appeal. At trial its lawyers argued that it sold lawful medicines prescribed by doctors and that pharmacists should not second-guess a doctor without real reason to suspect a prescription. The judgment is one of the largest single-company opioid outcomes obtained at trial rather than by settlement: nationwide opioid settlements total roughly $58 billion according to Reuters, and Albertsons itself announced a $774 million national settlement in April 2026, payable over nine years — a deal Washington declined to join, choosing to try its own case instead. The Attorney General's Office says its opioid recoveries for Washington state and local governments now total $2.17 billion, including a $100 million settlement with Purdue Pharma and the Sackler family in 2025.
Safeway and Albertsons pharmacies are everyday stops for families across the western United States, including Washington's large Punjabi community in the Seattle–Tacoma corridor and the truckers who run Interstate 5. The ruling sets a hard rule for every pharmacy chain: a prescription with warning signs may not be filled on trust — the check must happen, and it must be written down. For readers, the practical lesson is that questions from a pharmacist about a pain prescription are now a legal duty, not a courtesy.
What happens next
Albertsons must decide whether to appeal to the Washington Court of Appeals; the detailed findings of a nine-week bench trial are harder to overturn than a jury verdict, but the company has said all options are open. The state's attorneys' fees and costs will be fixed after a petition due within 21 days of the judgment. The $800 million abatement money will be paid into a state-established trust whose governing documents need court approval, with annual reports to the court on what was received, spent and achieved — so the first treatment and prevention spending decisions are expected to play out in public over the coming year. Awaaz Punjab will follow the appeal decision and the trust's first spending plan.